R & D at Boehringer Ingelheim
An introduction |
Andreas Barner, MD, PhDc
Vice Chairman of the Board of Managing Directors at Boehringer Ingelheim GmbH, responsible for R & D + M |
Video:
R & D at
Boehringer Ingelheim |
 |
The excitement of discovery
Basic research at the IMP |
Barry Dickson, PhD
Scientific Director of Research Institute of Molecular Pathology, IMP, Vienna |
Slides (PDF 1.65 MB) |
|
How to find tomorrow's cures in today's science
Boehringer Ingelheim's R & D expertise and research centres |
Mikael Dolsten, MD, PhD
Executive Vice President, Pharma Research Boehringer Ingelheim Pharmaceuticals Inc., USA |
Slides (PDF 0.75 MB) |
|
No better time for drug discovery
New compounds in oncology |
Wolfgang Rettig, MD, PhD
Head of Research, Boehringer Ingelheim Austria |
Slides (PDF 1.06 MB) |
|
Clinical research and beyond
Clinical Research programme
Further pipeline products |
Manfred Haehl, MD
Corporate Senior Vice President Medicine
Boehringer Ingelheim GmbH |
Slides (PDF 0.94 MB) |
|
